GLP-1 Compounded Injectible Tirzepatide contains the same active ingredient in Mounjaro®.  It’s a once-a-week injection, FDA-approved for the management of type 2 diabetes. It may be also be prescribed for weight loss and for chronic weight management in adults with obesity